The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-arm phase II study of afatinib treatment for advanced EGFR-mutant non-small cell lung cancer (mNSCLC) patients (pts) with EGFR-tyrosine kinase inhibitor (TKI) resistance.
 
Jair Bar
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Teva
Research Funding - Boehringer Ingelheim
 
Dana Botser
Travel, Accommodations, Expenses - Novartis
 
Rossie Navon
No Relationships to Disclose
 
Nir Peled
No Relationships to Disclose
 
Haim Biran
Travel, Accommodations, Expenses - BoH; Lilly
 
Einav Nili Gal-Yam
Honoraria - Roche Pharma AG
Travel, Accommodations, Expenses - Pfizer
 
Sayeh Ben-Arieh
Employment - MSD
 
Stephen Raskin
No Relationships to Disclose
 
Amir Onn
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche Pharma AG